Industry News
Cancer patients could benefit from the combining of Chinese and Western medicine
Oct 01, 2013
Combining traditional forms of Chinese and Western medicine could offer new hope for developing new treatments for liver, lung, colorectal cancers and osteosarcoma of the bones. Experts from Cardiff University's School of Medicine have joined forces with Peking University in China to test the health benefits of a traditional Chinese medicine... Read More
Erbitux significantly extends survival by 7.5 Months in mCRC RAS wild-type patients when compared with Bevacizumab: New analysis of FIRE-3 AIO study
Oct 01, 2013
Merck Serono, the biopharmaceutical division of Merck, has announced that the German cooperative investigator group AIO (Arbeitsgemeinschaft Internistische Onkologie) reported new data from the Phase III head-to-head clinical trial FIRE-3, which show a clinically relevant improvement from Erbitux® (cetuximab) plus FOLFIRI versus bevacizumab plus FOLFIRI as 1st line treatmen... Read More
Study published in Blood highlights Axl inhibition as a novel therapeutic approach for Acute Myeloid Leukemia
Oct 01, 2013
BerGenBio AS, an oncology biopharmaceutical company, announces that a paper entitled "Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine cross-talk of leukemia cells with bone marrow stroma"[1] by Ben-Batalla et al., has been published in Blood, the most cited peer-reviewed research journal in the field of hematology. The paper reports research directed by Dr... Read More
Evidence-guided tumour profiling offers new hope for clinicians managing difficult-to-treat cancers
Oct 01, 2013
Data from two studies presented at the 2013 European Cancer Congress (ECC 2013), announced by Caris Life Sciences, demonstrate the potential of evidence-guided tumour profiling to immediately improve the treatment of patients with hard-to-treat cancers, including cancers of unknown primary (CUP) and rarer and refractory cancers... Read More
The importance of telomere length in prostate cancer prognosis
Oct 01, 2013
Like the plastic caps at the end of shoelaces, telomeres protect - in their case - the interior-gene containing parts of chromosomes that carry a cell's instructional material... Read More
Progression of squamous cell carcinomas reduced in mice
Oct 01, 2013
The c-Fos oncogene has traditionally been linked to cellular activities related to cancer, such as cell division, differentiation - conversion from one cell type to another - or survival. Any alteration of these activities can set off the development of tumours, which has made c-Fos an important target for the understanding and treatment of cancer... Read More
Deadly form of lung cancer may be treatable with FDA-approved antidepressant
Oct 01, 2013
A little-used class of antidepressants appears potentially effective in combating a particularly deadly form of lung cancer, according to a new study from researchers at the Stanford University School of Medicine. And because the drugs have already been approved by the U.S... Read More
'Irrefutable' evidence that colorectal cancer screening has led to fall in death rates
Oct 01, 2013
Screening for colorectal cancer (CRC) in European countries is highly effective in reducing mortality from the disease... Read More
Melanoma patients treated with ipilimumab can survive up to 10 years
Oct 01, 2013
Patients with advanced melanoma, who have been treated with the monoclonal antibody, ipilimumab, can survive for up to ten years, according to the largest analysis of overall survival for these patients, presented at the 2013 European Cancer Congress (ECC2013) [1]... Read More
Increased mortality risk for younger patients with metastatic colorectal cancer
Oct 01, 2013
Younger patients with colorectal cancer that has spread (metastasised) to other parts of the body represent a high-risk group that is less likely to respond to anti-cancer treatments. Their disease is more likely to progress and they are at greater risk of death than other age groups, according to new reseach presented to the 2013 European Cancer Congress (ECC2013) [1]... Read More
Previous Page Next Page